New scan could sniff out hidden fungal infections

NCT ID NCT06105411

Recruiting now Diagnosis Sponsor: Peter MacCallum Cancer Centre, Australia Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a new type of PET scan that uses a radioactive fungal component to see if it can light up areas of Aspergillus infection in the body. Ten adults with suspected invasive fungal infections will receive the scan. The goal is to see if this method can accurately locate the infection, potentially leading to better diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 68Ga-labelled TAFC (a radiolabelled fungal siderophore)
What this could lead to: If it works, this could lead to a more accurate way to diagnose invasive fungal infections, helping doctors target treatment better.
What could go wrong: This is a very early, small study with only 10 participants, so results may not apply widely. The scan is experimental and may not improve diagnosis over current methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INVASIVE ASPERGILLOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

invasive aspergillosis Invasive Fungal Infections systemic mycosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INVASIVE FUNGAL INFECTIONS

Contacts and locations

Locations

Peter MacCallum Cancer Centre
RECRUITING

Melbourne, Victoria, 3000, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.